Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03669445
Title Study Association of Lenalidomide, Ixazomib, Dexamethasone and Daratumumab in Newly Diagnosed Standard Risk Multiple Myeloma (IFM2018-01)
Acronym IFM2018-01
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital, Toulouse
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Bordeaux NOT_YET_RECRUITING Bordeaux France Details
CHU de Caen NOT_YET_RECRUITING Caen France Details
CHU de Dijon NOT_YET_RECRUITING Dijon France Details
CHU de Grenoble NOT_YET_RECRUITING Grenoble France Details
CHRU de Lille NOT_YET_RECRUITING Lille France Details
Hospices Civils de Lyon NOT_YET_RECRUITING Lyon France Details
Institut Paoli Calmettes NOT_YET_RECRUITING Marseille France Details
CHRU de Nancy NOT_YET_RECRUITING Nancy France Details
CHU de Nantes NOT_YET_RECRUITING Nantes France Details
CHU de Rennes NOT_YET_RECRUITING Rennes France Details
University Hosptial Toulouse RECRUITING Toulouse 31000 France Details
CHU de Tours NOT_YET_RECRUITING Tours France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field